nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—IMPA1—mouth—head and neck cancer	0.0263	0.0914	CbGeAlD
Lithium—IMPA2—hair follicle—head and neck cancer	0.0252	0.0874	CbGeAlD
Lithium—GSK3B—hair follicle—head and neck cancer	0.0247	0.0858	CbGeAlD
Lithium—GSK3A—hair follicle—head and neck cancer	0.0215	0.0746	CbGeAlD
Lithium—IMPA2—parotid gland—head and neck cancer	0.0137	0.0478	CbGeAlD
Lithium—IMPA2—saliva-secreting gland—head and neck cancer	0.0132	0.0458	CbGeAlD
Lithium—GSK3B—connective tissue—head and neck cancer	0.0119	0.0412	CbGeAlD
Lithium—IMPA1—lymphoid tissue—head and neck cancer	0.0118	0.041	CbGeAlD
Lithium—GSK3A—parotid gland—head and neck cancer	0.0117	0.0408	CbGeAlD
Lithium—GSK3B—epithelium—head and neck cancer	0.0113	0.0392	CbGeAlD
Lithium—GSK3A—saliva-secreting gland—head and neck cancer	0.0112	0.039	CbGeAlD
Lithium—GSK3A—connective tissue—head and neck cancer	0.0103	0.0359	CbGeAlD
Lithium—IMPA2—trachea—head and neck cancer	0.0102	0.0353	CbGeAlD
Lithium—IMPA1—head—head and neck cancer	0.0095	0.033	CbGeAlD
Lithium—GSK3B—lymphoid tissue—head and neck cancer	0.00868	0.0302	CbGeAlD
Lithium—GSK3A—trachea—head and neck cancer	0.00867	0.0301	CbGeAlD
Lithium—GRIA3—head—head and neck cancer	0.00808	0.0281	CbGeAlD
Lithium—IMPA2—thyroid gland—head and neck cancer	0.00804	0.0279	CbGeAlD
Lithium—GSK3B—thyroid gland—head and neck cancer	0.00788	0.0274	CbGeAlD
Lithium—GSK3B—head—head and neck cancer	0.00699	0.0243	CbGeAlD
Lithium—GSK3A—thyroid gland—head and neck cancer	0.00685	0.0238	CbGeAlD
Lithium—Electrocardiogram change—Fluorouracil—head and neck cancer	0.00641	0.0628	CcSEcCtD
Lithium—GSK3A—head—head and neck cancer	0.00608	0.0211	CbGeAlD
Lithium—IMPA2—lymph node—head and neck cancer	0.00499	0.0173	CbGeAlD
Lithium—GSK3B—lymph node—head and neck cancer	0.0049	0.017	CbGeAlD
Lithium—GSK3A—lymph node—head and neck cancer	0.00426	0.0148	CbGeAlD
Lithium—Slurred speech—Fluorouracil—head and neck cancer	0.0041	0.0401	CcSEcCtD
Lithium—Nystagmus—Vinblastine—head and neck cancer	0.00391	0.0383	CcSEcCtD
Lithium—Skin ulcer—Hydroxyurea—head and neck cancer	0.00327	0.032	CcSEcCtD
Lithium—Chest tightness—Docetaxel—head and neck cancer	0.00282	0.0276	CcSEcCtD
Lithium—Nystagmus—Fluorouracil—head and neck cancer	0.00256	0.0251	CcSEcCtD
Lithium—Leukocytosis—Fluorouracil—head and neck cancer	0.00195	0.0191	CcSEcCtD
Lithium—Dysarthria—Fluorouracil—head and neck cancer	0.00194	0.019	CcSEcCtD
Lithium—Scotoma—Docetaxel—head and neck cancer	0.00174	0.0171	CcSEcCtD
Lithium—Coma—Fluorouracil—head and neck cancer	0.00167	0.0164	CcSEcCtD
Lithium—Swelling—Fluorouracil—head and neck cancer	0.00151	0.0148	CcSEcCtD
Lithium—Chest discomfort—Docetaxel—head and neck cancer	0.00149	0.0146	CcSEcCtD
Lithium—Weight increased—Hydroxyurea—head and neck cancer	0.00145	0.0142	CcSEcCtD
Lithium—Oliguria—Docetaxel—head and neck cancer	0.00143	0.0141	CcSEcCtD
Lithium—Drowsiness—Hydroxyurea—head and neck cancer	0.00142	0.0139	CcSEcCtD
Lithium—Lethargy—Fluorouracil—head and neck cancer	0.00136	0.0133	CcSEcCtD
Lithium—Hallucination—Hydroxyurea—head and neck cancer	0.00127	0.0125	CcSEcCtD
Lithium—Ataxia—Fluorouracil—head and neck cancer	0.00125	0.0122	CcSEcCtD
Lithium—Alopecia—Vinblastine—head and neck cancer	0.00124	0.0121	CcSEcCtD
Lithium—Dry skin—Fluorouracil—head and neck cancer	0.00122	0.0119	CcSEcCtD
Lithium—Muscular weakness—Fluorouracil—head and neck cancer	0.00117	0.0115	CcSEcCtD
Lithium—Alopecia—Hydroxyurea—head and neck cancer	0.00113	0.0111	CcSEcCtD
Lithium—Vertigo—Vinblastine—head and neck cancer	0.0011	0.0107	CcSEcCtD
Lithium—Swelling—Docetaxel—head and neck cancer	0.00109	0.0107	CcSEcCtD
Lithium—Convulsion—Vinblastine—head and neck cancer	0.00106	0.0104	CcSEcCtD
Lithium—Discomfort—Vinblastine—head and neck cancer	0.00103	0.0101	CcSEcCtD
Lithium—Lethargy—Docetaxel—head and neck cancer	0.000979	0.00959	CcSEcCtD
Lithium—Convulsion—Hydroxyurea—head and neck cancer	0.000964	0.00944	CcSEcCtD
Lithium—Anorexia—Vinblastine—head and neck cancer	0.000949	0.0093	CcSEcCtD
Lithium—Discomfort—Hydroxyurea—head and neck cancer	0.000936	0.00917	CcSEcCtD
Lithium—Oedema—Hydroxyurea—head and neck cancer	0.000908	0.00889	CcSEcCtD
Lithium—Ataxia—Docetaxel—head and neck cancer	0.000902	0.00884	CcSEcCtD
Lithium—Dehydration—Docetaxel—head and neck cancer	0.000893	0.00874	CcSEcCtD
Lithium—Dry skin—Docetaxel—head and neck cancer	0.00088	0.00862	CcSEcCtD
Lithium—Anorexia—Hydroxyurea—head and neck cancer	0.000866	0.00848	CcSEcCtD
Lithium—Decreased appetite—Vinblastine—head and neck cancer	0.000866	0.00848	CcSEcCtD
Lithium—Arrhythmia—Fluorouracil—head and neck cancer	0.000822	0.00805	CcSEcCtD
Lithium—Feeling abnormal—Vinblastine—head and neck cancer	0.00082	0.00804	CcSEcCtD
Lithium—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000814	0.00798	CcSEcCtD
Lithium—Alopecia—Fluorouracil—head and neck cancer	0.000813	0.00796	CcSEcCtD
Lithium—Somnolence—Hydroxyurea—head and neck cancer	0.000807	0.00791	CcSEcCtD
Lithium—Dyspepsia—Hydroxyurea—head and neck cancer	0.000799	0.00783	CcSEcCtD
Lithium—Decreased appetite—Hydroxyurea—head and neck cancer	0.000789	0.00773	CcSEcCtD
Lithium—Abdominal pain—Vinblastine—head and neck cancer	0.000787	0.00771	CcSEcCtD
Lithium—Fatigue—Hydroxyurea—head and neck cancer	0.000783	0.00767	CcSEcCtD
Lithium—Weight increased—Docetaxel—head and neck cancer	0.000755	0.00739	CcSEcCtD
Lithium—Vision blurred—Fluorouracil—head and neck cancer	0.000755	0.00739	CcSEcCtD
Lithium—Weight decreased—Docetaxel—head and neck cancer	0.00075	0.00735	CcSEcCtD
Lithium—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000748	0.00733	CcSEcCtD
Lithium—Body temperature increased—Hydroxyurea—head and neck cancer	0.000718	0.00703	CcSEcCtD
Lithium—Asthenia—Vinblastine—head and neck cancer	0.000714	0.007	CcSEcCtD
Lithium—Convulsion—Fluorouracil—head and neck cancer	0.000694	0.0068	CcSEcCtD
Lithium—Diarrhoea—Vinblastine—head and neck cancer	0.000681	0.00667	CcSEcCtD
Lithium—Discomfort—Fluorouracil—head and neck cancer	0.000674	0.0066	CcSEcCtD
Lithium—Confusional state—Fluorouracil—head and neck cancer	0.000659	0.00646	CcSEcCtD
Lithium—Dizziness—Vinblastine—head and neck cancer	0.000658	0.00645	CcSEcCtD
Lithium—Oedema—Fluorouracil—head and neck cancer	0.000654	0.0064	CcSEcCtD
Lithium—Asthenia—Hydroxyurea—head and neck cancer	0.000651	0.00638	CcSEcCtD
Lithium—Vomiting—Vinblastine—head and neck cancer	0.000633	0.0062	CcSEcCtD
Lithium—Headache—Vinblastine—head and neck cancer	0.000624	0.00611	CcSEcCtD
Lithium—Anorexia—Fluorouracil—head and neck cancer	0.000623	0.0061	CcSEcCtD
Lithium—Diarrhoea—Hydroxyurea—head and neck cancer	0.000621	0.00609	CcSEcCtD
Lithium—Hypotension—Fluorouracil—head and neck cancer	0.000611	0.00598	CcSEcCtD
Lithium—Dizziness—Hydroxyurea—head and neck cancer	0.0006	0.00588	CcSEcCtD
Lithium—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000595	0.00583	CcSEcCtD
Lithium—Arrhythmia—Docetaxel—head and neck cancer	0.000593	0.00581	CcSEcCtD
Lithium—Nausea—Vinblastine—head and neck cancer	0.000591	0.00579	CcSEcCtD
Lithium—Alopecia—Docetaxel—head and neck cancer	0.000587	0.00575	CcSEcCtD
Lithium—Somnolence—Fluorouracil—head and neck cancer	0.000581	0.00569	CcSEcCtD
Lithium—Vomiting—Hydroxyurea—head and neck cancer	0.000577	0.00566	CcSEcCtD
Lithium—Dyspepsia—Fluorouracil—head and neck cancer	0.000575	0.00564	CcSEcCtD
Lithium—Rash—Hydroxyurea—head and neck cancer	0.000573	0.00561	CcSEcCtD
Lithium—Dermatitis—Hydroxyurea—head and neck cancer	0.000572	0.0056	CcSEcCtD
Lithium—Headache—Hydroxyurea—head and neck cancer	0.000569	0.00557	CcSEcCtD
Lithium—Decreased appetite—Fluorouracil—head and neck cancer	0.000568	0.00557	CcSEcCtD
Lithium—Dysgeusia—Docetaxel—head and neck cancer	0.000566	0.00554	CcSEcCtD
Lithium—Nausea—Hydroxyurea—head and neck cancer	0.000539	0.00528	CcSEcCtD
Lithium—Feeling abnormal—Fluorouracil—head and neck cancer	0.000539	0.00528	CcSEcCtD
Lithium—Syncope—Docetaxel—head and neck cancer	0.000518	0.00508	CcSEcCtD
Lithium—Body temperature increased—Fluorouracil—head and neck cancer	0.000517	0.00506	CcSEcCtD
Lithium—Loss of consciousness—Docetaxel—head and neck cancer	0.000508	0.00498	CcSEcCtD
Lithium—Convulsion—Docetaxel—head and neck cancer	0.000501	0.00491	CcSEcCtD
Lithium—Arthralgia—Docetaxel—head and neck cancer	0.000492	0.00482	CcSEcCtD
Lithium—Dry mouth—Docetaxel—head and neck cancer	0.000481	0.00471	CcSEcCtD
Lithium—Confusional state—Docetaxel—head and neck cancer	0.000476	0.00466	CcSEcCtD
Lithium—Oedema—Docetaxel—head and neck cancer	0.000472	0.00462	CcSEcCtD
Lithium—Shock—Docetaxel—head and neck cancer	0.000464	0.00455	CcSEcCtD
Lithium—Anorexia—Docetaxel—head and neck cancer	0.00045	0.0044	CcSEcCtD
Lithium—Diarrhoea—Fluorouracil—head and neck cancer	0.000447	0.00438	CcSEcCtD
Lithium—Hypotension—Docetaxel—head and neck cancer	0.000441	0.00432	CcSEcCtD
Lithium—Dizziness—Fluorouracil—head and neck cancer	0.000432	0.00423	CcSEcCtD
Lithium—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00043	0.00421	CcSEcCtD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—PIK3CA—head and neck cancer	0.000429	0.000703	CbGpPWpGaD
Lithium—GSK3A—Insulin Signaling—AKT1—head and neck cancer	0.000429	0.000703	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—AKT1—head and neck cancer	0.000427	0.0007	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—MAPK3—head and neck cancer	0.000426	0.000698	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—AKT1—head and neck cancer	0.000425	0.000696	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—MAPK3—head and neck cancer	0.000424	0.000695	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—AKT1—head and neck cancer	0.000423	0.000693	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—AKT1—head and neck cancer	0.000421	0.00069	CbGpPWpGaD
Lithium—Somnolence—Docetaxel—head and neck cancer	0.000419	0.00411	CcSEcCtD
Lithium—GSK3A—Signaling by NGF—STAT3—head and neck cancer	0.000418	0.000686	CbGpPWpGaD
Lithium—Vomiting—Fluorouracil—head and neck cancer	0.000416	0.00407	CcSEcCtD
Lithium—Dyspepsia—Docetaxel—head and neck cancer	0.000415	0.00407	CcSEcCtD
Lithium—GSK3A—B Cell Activation—HRAS—head and neck cancer	0.000415	0.00068	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—AKT1—head and neck cancer	0.000415	0.00068	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—MAPK1—head and neck cancer	0.000413	0.000676	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—MAPK1—head and neck cancer	0.000413	0.000676	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—MAPK1—head and neck cancer	0.000413	0.000676	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—EGFR—head and neck cancer	0.000413	0.000676	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—EGFR—head and neck cancer	0.000413	0.000676	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—EGFR—head and neck cancer	0.000413	0.000676	CbGpPWpGaD
Lithium—Rash—Fluorouracil—head and neck cancer	0.000412	0.00404	CcSEcCtD
Lithium—Dermatitis—Fluorouracil—head and neck cancer	0.000412	0.00403	CcSEcCtD
Lithium—GSK3B—Downstream signaling of activated FGFR—PIK3CA—head and neck cancer	0.000411	0.000674	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PTGS2—head and neck cancer	0.000411	0.000673	CbGpPWpGaD
Lithium—Decreased appetite—Docetaxel—head and neck cancer	0.00041	0.00402	CcSEcCtD
Lithium—Headache—Fluorouracil—head and neck cancer	0.000409	0.00401	CcSEcCtD
Lithium—GSK3B—Signaling by EGFR—MAPK1—head and neck cancer	0.000409	0.00067	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—EGFR—head and neck cancer	0.000409	0.00067	CbGpPWpGaD
Lithium—Fatigue—Docetaxel—head and neck cancer	0.000407	0.00398	CcSEcCtD
Lithium—GSK3B—Signaling by EGFR in Cancer—MAPK1—head and neck cancer	0.000405	0.000664	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—EGFR—head and neck cancer	0.000405	0.000664	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000404	0.000663	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—MAPK1—head and neck cancer	0.000404	0.000661	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—EGFR—head and neck cancer	0.000403	0.000661	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—STAT3—head and neck cancer	0.000402	0.000659	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GRP—head and neck cancer	0.000401	0.000657	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—MAPK3—head and neck cancer	0.0004	0.000655	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—HRAS—head and neck cancer	0.000397	0.000651	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—HRAS—head and neck cancer	0.000397	0.000651	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—AKT1—head and neck cancer	0.000396	0.000649	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—AKT1—head and neck cancer	0.000396	0.000649	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—AKT1—head and neck cancer	0.000396	0.000649	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—AKT1—head and neck cancer	0.000392	0.000643	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—HRAS—head and neck cancer	0.000391	0.00064	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—MAPK1—head and neck cancer	0.00039	0.000639	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—EGFR—head and neck cancer	0.00039	0.000639	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—STAT6—head and neck cancer	0.000389	0.000638	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—AKT1—head and neck cancer	0.000389	0.000637	CbGpPWpGaD
Lithium—Feeling abnormal—Docetaxel—head and neck cancer	0.000389	0.00381	CcSEcCtD
Lithium—Nausea—Fluorouracil—head and neck cancer	0.000388	0.0038	CcSEcCtD
Lithium—GSK3B—Insulin Signaling—PIK3CA—head and neck cancer	0.000388	0.000636	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—AKT1—head and neck cancer	0.000387	0.000635	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—PIK3CA—head and neck cancer	0.000386	0.000633	CbGpPWpGaD
Lithium—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000386	0.00378	CcSEcCtD
Lithium—GSK3B—Signaling by FGFR—PIK3CA—head and neck cancer	0.000384	0.00063	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—MAPK3—head and neck cancer	0.000384	0.00063	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—PIK3CA—head and neck cancer	0.000382	0.000627	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—EGFR—head and neck cancer	0.000382	0.000626	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—PIK3CA—head and neck cancer	0.000381	0.000624	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—MAPK1—head and neck cancer	0.00038	0.000624	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—EGFR—head and neck cancer	0.00038	0.000623	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—HRAS—head and neck cancer	0.00038	0.000623	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CASP8—head and neck cancer	0.000375	0.000615	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—head and neck cancer	0.000375	0.000615	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—HRAS—head and neck cancer	0.000374	0.000613	CbGpPWpGaD
Lithium—Abdominal pain—Docetaxel—head and neck cancer	0.000373	0.00365	CcSEcCtD
Lithium—Body temperature increased—Docetaxel—head and neck cancer	0.000373	0.00365	CcSEcCtD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000372	0.000611	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—AKT1—head and neck cancer	0.000366	0.0006	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PTGS2—head and neck cancer	0.000366	0.0006	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—MAPK1—head and neck cancer	0.000365	0.000599	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—EGFR—head and neck cancer	0.000365	0.000599	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KISS1—head and neck cancer	0.00036	0.00059	CbGpPWpGaD
Lithium—GSK3B—Insulin Signaling—HRAS—head and neck cancer	0.000359	0.000589	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PTEN—head and neck cancer	0.000358	0.000587	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—PIK3CA—head and neck cancer	0.000358	0.000587	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—PIK3CA—head and neck cancer	0.000358	0.000587	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—PIK3CA—head and neck cancer	0.000358	0.000587	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—HRAS—head and neck cancer	0.000357	0.000586	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CDH1—head and neck cancer	0.000356	0.000584	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—HRAS—head and neck cancer	0.000356	0.000583	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—PIK3CA—head and neck cancer	0.000355	0.000582	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—HRAS—head and neck cancer	0.000354	0.00058	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—HRAS—head and neck cancer	0.000352	0.000577	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—PIK3CA—head and neck cancer	0.000352	0.000577	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—AKT1—head and neck cancer	0.000351	0.000575	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	0.000351	0.000575	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—PIK3CA—head and neck cancer	0.00035	0.000574	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—HRAS—head and neck cancer	0.000347	0.000569	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—PTEN—head and neck cancer	0.000346	0.000567	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—AKT1—head and neck cancer	0.000345	0.000566	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—NOTCH1—head and neck cancer	0.000345	0.000565	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—YAP1—head and neck cancer	0.000344	0.000564	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—BCL2L1—head and neck cancer	0.000339	0.000556	CbGpPWpGaD
Lithium—Asthenia—Docetaxel—head and neck cancer	0.000338	0.00332	CcSEcCtD
Lithium—GSK3B—Focal Adhesion—PIK3CA—head and neck cancer	0.000338	0.000555	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—AKT1—head and neck cancer	0.000336	0.00055	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—VEGFA—head and neck cancer	0.000333	0.000546	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—PIK3CA—head and neck cancer	0.000331	0.000543	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—HRAS—head and neck cancer	0.000331	0.000543	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—HRAS—head and neck cancer	0.000331	0.000543	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—HRAS—head and neck cancer	0.000331	0.000543	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—AKT1—head and neck cancer	0.00033	0.000542	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—PIK3CA—head and neck cancer	0.00033	0.000541	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—STAT3—head and neck cancer	0.00033	0.00054	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—HRAS—head and neck cancer	0.000328	0.000538	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—HRAS—head and neck cancer	0.000325	0.000533	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—HRAS—head and neck cancer	0.000324	0.000531	CbGpPWpGaD
Lithium—Diarrhoea—Docetaxel—head and neck cancer	0.000323	0.00316	CcSEcCtD
Lithium—GSK3A—Innate Immune System—BCL2—head and neck cancer	0.000322	0.000528	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PTEN—head and neck cancer	0.000319	0.000523	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—PIK3CA—head and neck cancer	0.000317	0.00052	CbGpPWpGaD
Lithium—GSK3B—Insulin Signaling—AKT1—head and neck cancer	0.000317	0.00052	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—AKT1—head and neck cancer	0.000316	0.000517	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—MAPK3—head and neck cancer	0.000315	0.000516	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—AKT1—head and neck cancer	0.000314	0.000515	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—HRAS—head and neck cancer	0.000313	0.000513	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—TP53—head and neck cancer	0.000313	0.000513	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—AKT1—head and neck cancer	0.000312	0.000512	CbGpPWpGaD
Lithium—Dizziness—Docetaxel—head and neck cancer	0.000312	0.00306	CcSEcCtD
Lithium—GSK3B—DAP12 signaling—AKT1—head and neck cancer	0.000311	0.00051	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—STAT3—head and neck cancer	0.000309	0.000507	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—HRAS—head and neck cancer	0.000307	0.000503	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—AKT1—head and neck cancer	0.000306	0.000502	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—HRAS—head and neck cancer	0.000305	0.000501	CbGpPWpGaD
Lithium—Vomiting—Docetaxel—head and neck cancer	0.0003	0.00294	CcSEcCtD
Lithium—GSK3B—Cellular responses to stress—MAPK1—head and neck cancer	0.0003	0.000491	CbGpPWpGaD
Lithium—Rash—Docetaxel—head and neck cancer	0.000297	0.00291	CcSEcCtD
Lithium—Dermatitis—Docetaxel—head and neck cancer	0.000297	0.00291	CcSEcCtD
Lithium—GSK3B—Signaling Pathways—GRP—head and neck cancer	0.000296	0.000485	CbGpPWpGaD
Lithium—Headache—Docetaxel—head and neck cancer	0.000296	0.00289	CcSEcCtD
Lithium—GSK3B—Signaling by NGF—MAPK3—head and neck cancer	0.000295	0.000484	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—HRAS—head and neck cancer	0.000293	0.000481	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—AKT1—head and neck cancer	0.000293	0.000479	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—AKT1—head and neck cancer	0.000293	0.000479	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—AKT1—head and neck cancer	0.000293	0.000479	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—AKT1—head and neck cancer	0.00029	0.000475	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—STAT6—head and neck cancer	0.000288	0.000471	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—AKT1—head and neck cancer	0.000287	0.000471	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—AKT1—head and neck cancer	0.000286	0.000469	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—VEGFA—head and neck cancer	0.000283	0.000463	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—MAPK1—head and neck cancer	0.000281	0.000461	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—EGFR—head and neck cancer	0.000281	0.000461	CbGpPWpGaD
Lithium—Nausea—Docetaxel—head and neck cancer	0.00028	0.00274	CcSEcCtD
Lithium—GSK3B—Innate Immune System—CASP8—head and neck cancer	0.000277	0.000455	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—AKT1—head and neck cancer	0.000276	0.000453	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—AKT1—head and neck cancer	0.000271	0.000444	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—AKT1—head and neck cancer	0.00027	0.000442	CbGpPWpGaD
Lithium—GSK3A—Immune System—BCL2L1—head and neck cancer	0.000267	0.000438	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—MAPK3—head and neck cancer	0.000267	0.000438	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—PTEN—head and neck cancer	0.000267	0.000437	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CDH1—head and neck cancer	0.000263	0.000431	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	0.000259	0.000425	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—PTEN—head and neck cancer	0.000256	0.00042	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—YAP1—head and neck cancer	0.000254	0.000417	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—MAPK1—head and neck cancer	0.000254	0.000417	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—EGFR—head and neck cancer	0.000254	0.000417	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PIK3CA—head and neck cancer	0.000253	0.000414	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—TP53—head and neck cancer	0.000252	0.000412	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—AKT1—head and neck cancer	0.000248	0.000406	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—PIK3CA—head and neck cancer	0.000244	0.0004	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—AKT1—head and neck cancer	0.00024	0.000393	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—BCL2—head and neck cancer	0.000238	0.00039	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MAPK3—head and neck cancer	0.000228	0.000374	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—HRAS—head and neck cancer	0.000226	0.00037	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PIK3CA—head and neck cancer	0.000225	0.000369	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—AKT1—head and neck cancer	0.000223	0.000365	CbGpPWpGaD
Lithium—GSK3A—Disease—NOTCH1—head and neck cancer	0.000222	0.000363	CbGpPWpGaD
Lithium—GSK3A—Immune System—CASP8—head and neck cancer	0.000219	0.000358	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MAPK1—head and neck cancer	0.000217	0.000356	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—EGFR—head and neck cancer	0.000217	0.000356	CbGpPWpGaD
Lithium—GSK3A—Immune System—CDH1—head and neck cancer	0.000216	0.000354	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—EGFR—head and neck cancer	0.000208	0.000341	CbGpPWpGaD
Lithium—IMPA2—Metabolism—AKT1—head and neck cancer	0.000206	0.000338	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—HRAS—head and neck cancer	0.000204	0.000335	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—VEGFA—head and neck cancer	0.000202	0.000331	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—STAT3—head and neck cancer	0.0002	0.000327	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—AKT1—head and neck cancer	0.000199	0.000327	CbGpPWpGaD
Lithium—GSK3B—Immune System—BCL2L1—head and neck cancer	0.000198	0.000324	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—PTEN—head and neck cancer	0.000197	0.000323	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MAPK3—head and neck cancer	0.000191	0.000313	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PTEN—head and neck cancer	0.000189	0.00031	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—PIK3CA—head and neck cancer	0.000188	0.000309	CbGpPWpGaD
Lithium—GSK3A—Immune System—BCL2—head and neck cancer	0.000188	0.000308	CbGpPWpGaD
Lithium—IMPA1—Metabolism—AKT1—head and neck cancer	0.000184	0.000302	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—AKT1—head and neck cancer	0.000184	0.000301	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MAPK1—head and neck cancer	0.000182	0.000298	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—EGFR—head and neck cancer	0.000182	0.000298	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—PIK3CA—head and neck cancer	0.000181	0.000296	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—HRAS—head and neck cancer	0.000174	0.000286	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MAPK3—head and neck cancer	0.000169	0.000276	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—HRAS—head and neck cancer	0.000167	0.000274	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL2—head and neck cancer	0.000165	0.000271	CbGpPWpGaD
Lithium—GSK3A—Disease—PTGS2—head and neck cancer	0.000165	0.00027	CbGpPWpGaD
Lithium—GSK3B—Disease—NOTCH1—head and neck cancer	0.000164	0.000268	CbGpPWpGaD
Lithium—GSK3B—Immune System—CASP8—head and neck cancer	0.000162	0.000265	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MAPK1—head and neck cancer	0.00016	0.000263	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—EGFR—head and neck cancer	0.00016	0.000263	CbGpPWpGaD
Lithium—GSK3B—Immune System—CDH1—head and neck cancer	0.00016	0.000262	CbGpPWpGaD
Lithium—GSK3A—Immune System—PTEN—head and neck cancer	0.000155	0.000255	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOTCH1—head and neck cancer	0.000155	0.000254	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—EGFR—head and neck cancer	0.000154	0.000252	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—AKT1—head and neck cancer	0.000154	0.000252	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—AKT1—head and neck cancer	0.000148	0.000242	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—HRAS—head and neck cancer	0.000146	0.000239	CbGpPWpGaD
Lithium—GSK3A—Disease—PTEN—head and neck cancer	0.000144	0.000235	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—PIK3CA—head and neck cancer	0.000139	0.000228	CbGpPWpGaD
Lithium—GSK3A—Immune System—STAT3—head and neck cancer	0.000139	0.000228	CbGpPWpGaD
Lithium—GSK3B—Immune System—BCL2—head and neck cancer	0.000139	0.000227	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PIK3CA—head and neck cancer	0.000134	0.000219	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAPK3—head and neck cancer	0.000133	0.000218	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—HRAS—head and neck cancer	0.000129	0.000211	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—AKT1—head and neck cancer	0.000129	0.000211	CbGpPWpGaD
Lithium—GSK3A—Disease—STAT3—head and neck cancer	0.000128	0.00021	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAPK1—head and neck cancer	0.000126	0.000207	CbGpPWpGaD
Lithium—GSK3A—Immune System—EGFR—head and neck cancer	0.000126	0.000207	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HRAS—head and neck cancer	0.000124	0.000203	CbGpPWpGaD
Lithium—GSK3A—Disease—MAPK3—head and neck cancer	0.000123	0.000201	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL2—head and neck cancer	0.000122	0.0002	CbGpPWpGaD
Lithium—GSK3B—Disease—PTGS2—head and neck cancer	0.000122	0.000199	CbGpPWpGaD
Lithium—GSK3A—Disease—MAPK1—head and neck cancer	0.000117	0.000191	CbGpPWpGaD
Lithium—GSK3A—Disease—EGFR—head and neck cancer	0.000117	0.000191	CbGpPWpGaD
Lithium—GSK3B—Immune System—PTEN—head and neck cancer	0.000115	0.000188	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOTCH1—head and neck cancer	0.000115	0.000188	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—AKT1—head and neck cancer	0.000114	0.000186	CbGpPWpGaD
Lithium—GSK3A—Immune System—PIK3CA—head and neck cancer	0.00011	0.00018	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—AKT1—head and neck cancer	0.000109	0.000179	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL2—head and neck cancer	0.000107	0.000175	CbGpPWpGaD
Lithium—GSK3B—Disease—PTEN—head and neck cancer	0.000106	0.000174	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCND1—head and neck cancer	0.000104	0.000171	CbGpPWpGaD
Lithium—GSK3B—Immune System—STAT3—head and neck cancer	0.000103	0.000168	CbGpPWpGaD
Lithium—GSK3A—Immune System—HRAS—head and neck cancer	0.000101	0.000166	CbGpPWpGaD
Lithium—GSK3A—Disease—PIK3CA—head and neck cancer	0.000101	0.000166	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PTEN—head and neck cancer	0.0001	0.000165	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAPK3—head and neck cancer	9.81e-05	0.000161	CbGpPWpGaD
Lithium—GSK3B—Disease—STAT3—head and neck cancer	9.48e-05	0.000155	CbGpPWpGaD
Lithium—GSK3A—Disease—HRAS—head and neck cancer	9.37e-05	0.000154	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAPK1—head and neck cancer	9.34e-05	0.000153	CbGpPWpGaD
Lithium—GSK3B—Immune System—EGFR—head and neck cancer	9.34e-05	0.000153	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—VEGFA—head and neck cancer	9.08e-05	0.000149	CbGpPWpGaD
Lithium—GSK3B—Disease—MAPK3—head and neck cancer	9.06e-05	0.000149	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—STAT3—head and neck cancer	8.99e-05	0.000147	CbGpPWpGaD
Lithium—GSK3A—Immune System—AKT1—head and neck cancer	8.96e-05	0.000147	CbGpPWpGaD
Lithium—GSK3B—Disease—MAPK1—head and neck cancer	8.62e-05	0.000141	CbGpPWpGaD
Lithium—GSK3B—Disease—EGFR—head and neck cancer	8.62e-05	0.000141	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAPK3—head and neck cancer	8.59e-05	0.000141	CbGpPWpGaD
Lithium—GSK3A—Disease—AKT1—head and neck cancer	8.27e-05	0.000136	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAPK1—head and neck cancer	8.17e-05	0.000134	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—EGFR—head and neck cancer	8.17e-05	0.000134	CbGpPWpGaD
Lithium—GSK3B—Immune System—PIK3CA—head and neck cancer	8.1e-05	0.000133	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL2—head and neck cancer	7.89e-05	0.000129	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCND1—head and neck cancer	7.69e-05	0.000126	CbGpPWpGaD
Lithium—GSK3B—Immune System—HRAS—head and neck cancer	7.5e-05	0.000123	CbGpPWpGaD
Lithium—GSK3B—Disease—PIK3CA—head and neck cancer	7.48e-05	0.000123	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTEN—head and neck cancer	7.43e-05	0.000122	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PIK3CA—head and neck cancer	7.09e-05	0.000116	CbGpPWpGaD
Lithium—GSK3B—Disease—HRAS—head and neck cancer	6.92e-05	0.000113	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TP53—head and neck cancer	6.86e-05	0.000112	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—VEGFA—head and neck cancer	6.71e-05	0.00011	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—STAT3—head and neck cancer	6.64e-05	0.000109	CbGpPWpGaD
Lithium—GSK3B—Immune System—AKT1—head and neck cancer	6.62e-05	0.000109	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HRAS—head and neck cancer	6.56e-05	0.000108	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAPK3—head and neck cancer	6.35e-05	0.000104	CbGpPWpGaD
Lithium—GSK3B—Disease—AKT1—head and neck cancer	6.11e-05	0.0001	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAPK1—head and neck cancer	6.04e-05	9.9e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EGFR—head and neck cancer	6.04e-05	9.89e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKT1—head and neck cancer	5.79e-05	9.49e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PIK3CA—head and neck cancer	5.24e-05	8.59e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TP53—head and neck cancer	5.07e-05	8.31e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HRAS—head and neck cancer	4.85e-05	7.94e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKT1—head and neck cancer	4.28e-05	7.02e-05	CbGpPWpGaD
